Effect of GRP119 Receptor Agonist, Compound MBX-2982, on Activity of Human Glucokinase


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Validation of the method for studies of glucokinase activators by the spectrophotometric method in an in vitro test system is carried out. The advantage of NAD coenzyme vs. thio-NAD is proven. Manifest activation of glucokinase by MBX-2982 compound (GPR119 agonist) in a wide range of concentrations is demonstrated experimentally.

Sobre autores

A. Spasov

Volgograd State Medical University, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: aspasov@mail.ru
Rússia, Volgograd

V. Kosolapov

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: aspasov@mail.ru
Rússia, Volgograd

D. Babkov

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: aspasov@mail.ru
Rússia, Volgograd

O. Maika

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: aspasov@mail.ru
Rússia, Volgograd


Declaração de direitos autorais © Springer Science+Business Media, LLC, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies